Tennessee Seeks To Shield Execution Drug Supplier After Botched Pike Lethal Injection

Tennessee officials have asked a Nashville judge to block death row inmate Christa Pike's attorneys from seeing even a single label on the execution drug vials preserved from her botched September 30 lethal injection, warning that executions could halt if the supplier is exposed.^[1]

In a motion filed Friday, November 6, in Davidson County Chancery Court, the state argued that allowing Pike's legal team or experts to inspect or handle the pentobarbital vials in ways that might reveal the manufacturer would violate confidentiality promises and likely cause the vendor to cut ties with Tennessee, jeopardizing all future lethal injections.^[1] A Tennessee Department of Correction employee responsible for obtaining pentobarbital told the court the current supplier already fears threats, harassment and boycotts and has warned that it will stop doing business with the state if its identity becomes public.^[1]

The state's request seeks to modify or clarify an October 10 preservation order from Chancellor I'Ashea Myles, which required officials to retain the pentobarbital vials and related materials after Pike's execution attempt was called off mid-process.^[1] Tennessee now wants the court to shield any identifying information on those vials from defense counsel and their experts, arguing that losing its current vendor would effectively shut down the state's ability to carry out death sentences using pentobarbital.^[1]

Pike, the only woman on Tennessee's death row, was scheduled to be executed by lethal injection on September 30, but the procedure was halted after problems emerged with the condemned woman's intravenous lines and the administration of the drug, prompting legal challenges and renewed scrutiny of the state's execution protocols.^[1] Her attorneys have pressed for access to evidence surrounding the failed execution, including the preserved pentobarbital vials, to investigate what went wrong and whether Tennessee's methods violate constitutional protections against cruel and unusual punishment.^[1]

Tennessee, like many death-penalty states, has increasingly relied on secrecy to maintain access to execution drugs as pharmaceutical companies and medical suppliers have withdrawn from the lethal-injection business under pressure from activists, professional organizations and shareholders. The new filing underscores that strategy, explicitly tying the survival of the state's pentobarbital supply to strict anonymity for the vendor and placing the courts in the middle of a clash between transparency in a botched execution case and the practical mechanics of continuing capital punishment.^[1] Chancellor Myles has not yet ruled on the state's request.

1. Fox News